Tenax Therapeutics Inc (NASDAQ:TENX)

3.15
Delayed Data
As of Feb 27
 -0.05 / -1.56%
Today’s Change
3.01
Today|||52-Week Range
8.35
-17.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$91.9M

Company Description

Tenax Therapeutics, Inc. engages in developing biotechnology products, which focuses on oxygen delivery to specific target tissues. The company has developed a proprietary perfluorocarbon therapeutic oxygen carrier called Oxycyte that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke. It is also developing PFC-based creams and gels for topical delivery to the skin for dermatologic conditions and potentially wound care. In addition, the company has commercialized its Dermacyte line of skin care cosmetics for the anti-aging market. Tenax Therapeutics was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Contact Information

Tenax Therapeutics, Inc.
One Copley Parkway
Morrisville North Carolina 27560
P:(919) 855-2100
Investor Relations:
(919) 855-2112

Employees

Shareholders

Mutual fund holders4.49%
Other institutional33.44%
Individual stakeholders0.32%

Top Executives

John P. KelleyChief Executive Officer & Director
Michael B. JebsenChief Financial Officer & Treasurer
Timothy BradshawExecutive Vice President-Clinical Development
Paula BokeschChief Medical Officer
Doug RandallExecutive VP-Business & Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account